{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:43:29Z","timestamp":1791855809229,"version":"4.3.4"},"reference-count":125,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:00:00Z","timestamp":1759017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Antibodies"],"abstract":"<jats:p>Primary podocytopathies, including minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS), are caused by a circulating factor or factors injurious to the podocyte. An immunologic origin seems likely based on responsiveness to corticosteroids or other immunosuppressive agents, including calcineurin inhibitors targeting T-cells and rituximab targeting B-cells. Potential non-antibody-mediated circulating factors have been identified, including cardiotrophin-like cytokine 1, soluble urokinase plasminogen activator receptor, and angiopoietin-like 4, among others. More recent research supports a primary antibody pathogenesis, with anti-nephrin antibodies found in a significant percentage of cases. Such antibodies also predict recurrence after transplantation. Other potential antigenic targets besides nephrin include annexin, the proteosome, podocin, and CD40. Additionally, high-resolution confocal microscopy has identified punctate immunoglobulin deposits along the slit diaphragm and podocyte cell body that may or may not colocalize with abnormal punctate nephrin staining and may correlate with detectable circulating antibodies. The success of rituximab in observational studies in both native kidneys and transplants supports a primary role for autoantibodies. We discuss in detail the data supporting putative non-antibody circulating factors, as well as the recent data supporting antibody pathogenesis, which may provide some clues on treating the individual patient.<\/jats:p>","DOI":"10.3390\/antib14040082","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T09:12:23Z","timestamp":1759223543000},"page":"82","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Serum Factors in Primary Podocytopathies"],"prefix":"10.3390","volume":"14","author":[{"given":"Edward John","family":"Filippone","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, 2228 south Broad St, Philadelphia, PA 19145, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Farber","sequence":"additional","affiliation":[{"name":"Department of Pathology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19145, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","article-title":"Pathologic classification of focal segmental glomerulosclerosis: A working proposal","volume":"43","author":"Fogo","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.05000516","article-title":"Minimal change disease","volume":"12","author":"Vivarelli","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000442999","article-title":"Primary FSGS in nephrotic adults: Clinical profile, response to immunosuppression and outcome","volume":"132","author":"Bagchi","year":"2016","journal-title":"Nephron"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2215\/CJN.05960616","article-title":"Focal segmental glomerulosclerosis","volume":"12","author":"Rosenberg","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2215\/CJN.08970719","article-title":"Recurrence of FSGS after kidney transplantation in adults","volume":"15","author":"Uffing","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrneph.2016.147","article-title":"Minimal change disease and idiopathic FSGS: Manifestations of the same disease","volume":"12","author":"Maas","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","article-title":"Pathogenesis of lipoid nephrosis: A disorder of t-cell function","volume":"304","author":"Shalhoub","year":"1974","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1681\/ASN.2021060794","article-title":"Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology","volume":"33","author":"Watts","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.kint.2023.11.022","article-title":"A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrence","volume":"105","author":"Shirai","year":"2024","journal-title":"Kidney Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/nep.14249","article-title":"A pilot study of anti-nephrin antibodies in podocytopaties among adults","volume":"29","author":"Chebotareva","year":"2024","journal-title":"Nephrology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.ekir.2024.05.003","article-title":"Clinical characteristics of nephrin autoantibody-positive minimal change disease in older adults","volume":"9","author":"Fujita","year":"2024","journal-title":"Kidney Int. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.kint.2024.07.022","article-title":"Pre-transplant anti-nephrin antibodies are specific predictors of recurrent diffuse podocytopathy in the kidney allograft","volume":"106","author":"Batal","year":"2024","journal-title":"Kidney Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa2314471","article-title":"Autoantibodies targeting nephrin in podocytopathies","volume":"391","author":"Hengel","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"sfaf012","DOI":"10.1093\/ckj\/sfaf012","article-title":"Anti-nephrin antibody: A potential biomarker of minimal change disease","volume":"18","author":"Chen","year":"2025","journal-title":"Clin. Kidney J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.kint.2025.02.028","article-title":"Anti-nephrin antibodies in adult chinese patients with minimal change disease and primary focal segmental glomerulosclerosis","volume":"108","author":"Shu","year":"2025","journal-title":"Kidney Int."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00467-023-06107-5","article-title":"Anti-nephrin antibodies in steroid-sensitive nephrotic syndrome in japanese children","volume":"39","author":"Horinouchi","year":"2024","journal-title":"Pediatr. Nephrol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10.1681","DOI":"10.1681\/ASN.20243svtqzfb","article-title":"Circulating anti-nephrin antibodies in idiopathic nephrotic syndrome: A large cohort study testing association with disease activity: TH-OR94","volume":"35","author":"Angeletti","year":"2024","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ekir.2024.11.028","article-title":"Detection of antinephrin antibodies in childhood idiopathic nephrotic syndrome","volume":"10","author":"Bianchi","year":"2024","journal-title":"Kidney Int. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.kint.2025.01.019","article-title":"Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategy","volume":"107","author":"Hengel","year":"2025","journal-title":"Kidney Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.kint.2024.09.006","article-title":"Anti-slit diaphragm antibodies on kidney biopsy identify pediatric patients with steroid-resistant nephrotic syndrome responsive to second-line immunosuppressants","volume":"106","author":"Raglianti","year":"2024","journal-title":"Kidney Int."},{"key":"ref_21","first-page":"37","article-title":"A vascular permeability factor elaborated from lymphocytes. I. demonstration in patients with nephrotic syndrome","volume":"23","author":"Lagrue","year":"1975","journal-title":"Biomedicine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.4049\/jimmunol.119.4.1230","article-title":"Physicochemical characterization of a vascular permeability factor produced by con A-stimulated human lymphocytes","volume":"119","author":"Sobel","year":"1977","journal-title":"J. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000183572","article-title":"Studies of vascular permeability factor derived from T lymphocytes and inhibitory effect of plasma on its production in minimal change nephrotic syndrome","volume":"41","author":"Tomizawa","year":"1985","journal-title":"Nephron"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000183664","article-title":"The vascular permeability factor is a T lymphocyte product","volume":"42","author":"Heslan","year":"1986","journal-title":"Nephron"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00858545","article-title":"Do circulating factors play a role in the pathogenesis of minimal change nephrotic syndrome?","volume":"3","author":"Bakker","year":"1989","journal-title":"Pediatr. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1159\/000189457","article-title":"Minimal change-like glomerular alterations induced by a human plasma factor","volume":"74","author":"Cheung","year":"1996","journal-title":"Nephron"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1681\/ASN.V1081700","article-title":"Is 100KF an isoform of hemopexin? immunochemical characterization of the vasoactive plasma factor 100KF","volume":"10","author":"Cheung","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1681\/ASN.2007080940","article-title":"Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes","volume":"19","author":"Lennon","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1681\/ASN.V361260","article-title":"Measurement of albumin reflection coefficient with isolated rat glomeruli","volume":"3","author":"Savin","year":"1992","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM199604043341402","article-title":"Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis","volume":"334","author":"Savin","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/ajkd.1998.v32.pm9708606","article-title":"Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys","volume":"32","author":"Feld","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/01.ASN.0000046960.57614.17","article-title":"Serial estimates of serum permeability activity and clinical correlates in patients with native kidney focal segmental glomerulosclerosis","volume":"14","author":"Cattran","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1681\/ASN.V103552","article-title":"\u201cThe FSGS factor\u201d: Enrichment and: In vivo: Effect of activity from focal segmental glomerulosclerosis plasma","volume":"10","author":"Sharma","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/153537020422900111","article-title":"The focal segmental glomerulosclerosis permeability factor: Biochemical characteristics and biological effects","volume":"229","author":"Sharma","year":"2004","journal-title":"Exp. Biol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1097\/00007890-199612270-00041","article-title":"Cyclosporine Protects Glomeruli From Fsgs Factor Via an Increase in Glomerular cAMP1,2","volume":"62","author":"Sharma","year":"1996","journal-title":"Transplantation"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1111\/j.1523-1755.2000.00369.x","article-title":"Components of normal serum block the focal segmental glomerulosclerosis factor activity in vitro","volume":"58","author":"Sharma","year":"2000","journal-title":"Kidney Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1681\/ASN.V121143","article-title":"Apolipoproteins prevent glomerular albumin permeability induced in vitro by serum from patients with focal segmental glomerulosclerosis","volume":"12","author":"Candiano","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1046\/j.1523-1755.2002.00172.x","article-title":"Indomethacin protects permeability barrier from focal segmental glomerulosclerosis serum","volume":"61","author":"McCarthy","year":"2002","journal-title":"Kidney Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1093\/ndt\/12.10.2064","article-title":"Inhibitory effect of tripterygium wilfordii multiglycoside on increased glomerular albumin permeability in vitro","volume":"12","author":"Sharma","year":"1997","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.trsl.2015.03.002","article-title":"Janus kinase 2\/signal transducer and activator of transcription 3 inhibitors attenuate the effect of cardiotrophin-like cytokine factor 1 and human focal segmental glomerulosclerosis serum on glomerular filtration barrier","volume":"166","author":"Sharma","year":"2015","journal-title":"Transl. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2019.11.011","article-title":"The zinc fingers and homeoboxes 2 protein ZHX2 and its interacting proteins regulate upstream pathways in podocyte diseases","volume":"97","author":"Marshall","year":"2020","journal-title":"Kidney Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"F685","DOI":"10.1152\/ajprenal.00219.2023","article-title":"\u201cIdiopathic\u201d minimal change nephrotic syndrome: A podocyte mystery nears the end","volume":"325","author":"Chugh","year":"2023","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e166012","DOI":"10.1172\/jci.insight.166012","article-title":"Cytokine storm-based mechanisms for extrapulmonary manifestations of SARS-CoV-2 infection","volume":"8","author":"Avila","year":"2023","journal-title":"JCI Insight"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3396","article-title":"Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome","volume":"20","author":"Clement","year":"2014","journal-title":"Nat. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nm.2261","article-title":"Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome","volume":"17","author":"Clement","year":"2011","journal-title":"Nat. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ccr.2011.01.018","article-title":"Angiopoietin-like 4 protein elevates the prosurvival intracellular O2(-):H2O2 ratio and confers anoikis resistance to tumors","volume":"19","author":"Zhu","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbrc.2022.11.081","article-title":"ANGPTL4 promotes nephrotic syndrome by downregulating podocyte expression of ACTN4 and podocin","volume":"639","author":"Li","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Cara-Fuentes, G., Segarra, A., Silva-Sanchez, C., Wang, H., Lanaspa, M.A., Johnson, R.J., and Garin, E.H. (2017). Angiopoietin-like-4 and minimal change disease. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0176198"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrm2821","article-title":"Regulation of cell signalling by uPAR","volume":"11","author":"Smith","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"120303","DOI":"10.1016\/j.cca.2025.120303","article-title":"suPAR as a biomarker of support in different clinical settings","volume":"573","author":"Belvederi","year":"2025","journal-title":"Clin. Chim. Acta"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Wei, C., Spear, R., Hahm, E., and Reiser, J. (2021). suPAR, a circulating kidney disease factor. Front. Med., 8, Available online: https:\/\/www.frontiersin.org\/journals\/medicine\/articles\/10.3389\/fmed.2021.745838.","DOI":"10.3389\/fmed.2021.745838"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/sji.12082","article-title":"Fibroblast growth factor 23, hepatocyte growth factor, Interleukin-6, High-Sensitivity C-Reactive protein and soluble urokinase plasminogen activator receptor inflammation markers in chronic haemodialysis patients?","volume":"78","author":"Almroth","year":"2013","journal-title":"Scand. J. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa1506362","article-title":"Soluble urokinase receptor and chronic kidney disease","volume":"373","author":"Hayek","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/joim.12269","article-title":"Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes","volume":"277","author":"Theilade","year":"2015","journal-title":"J. Intern. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm1696","article-title":"Modification of kidney barrier function by the urokinase receptor","volume":"14","author":"Wei","year":"2008","journal-title":"Nat. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis","volume":"17","author":"Wei","year":"2011","journal-title":"Nat. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1681\/ASN.2012030302","article-title":"Circulating suPAR in two cohorts of primary FSGS","volume":"23","author":"Wei","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nm.4242","article-title":"Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease","volume":"23","author":"Hahm","year":"2017","journal-title":"Nat. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"13647","DOI":"10.1038\/srep13647","article-title":"Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes","volume":"5","author":"Alfano","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1681\/ASN.2013040425","article-title":"Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice","volume":"25","author":"Cathelin","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/ki.2014.346","article-title":"A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease","volume":"87","author":"Spinale","year":"2015","journal-title":"Kidney Int."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2215\/CJN.07680712","article-title":"Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: A single-center report","volume":"8","author":"Bock","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/ki.2013.55","article-title":"Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis","volume":"84","author":"Huang","year":"2013","journal-title":"Kidney Int."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/ki.2013.505","article-title":"The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis","volume":"85","author":"Meijers","year":"2014","journal-title":"Kidney Int."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/ki.2013.546","article-title":"Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children","volume":"85","author":"Sinha","year":"2014","journal-title":"Kidney Int."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1681\/ASN.2013111213","article-title":"Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease","volume":"26","author":"Yoo","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","article-title":"Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis","volume":"3","author":"Fornoni","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2498628","DOI":"10.1080\/0886022X.2025.2498628","article-title":"The predictive value of suPAR for glomerular segmental sclerosis lesions in renal pathology","volume":"47","author":"Zhang","year":"2025","journal-title":"Ren. Fail."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Beaudreuil, S., Zhang, X., Herr, F., Harper, F., Candelier, J.J., Fan, Y., Yeter, H., Dudreuilh, C., Lecru, L., and Vazquez, A. (2019). Circulating CASK is associated with recurrent focal segmental glomerulosclerosis after transplantation. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0219353"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Bharati, J., Kumar, M., Kumar, N., Malhotra, A., and Singhal, P.C. (2023). MicroRNA193a: An emerging mediator of glomerular diseases. Biomolecules, 13.","DOI":"10.3390\/biom13121743"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2215\/CJN.11561113","article-title":"Evaluation of microRNAs miR-196a, miR-30a-5P, and miR-490 as biomarkers of disease activity among patients with FSGS","volume":"9","author":"Zhang","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nm.3142","article-title":"Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1","volume":"19","author":"Gebeshuber","year":"2013","journal-title":"Nat. Med."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Wang, L., Wang, J., Wang, Z., Zhou, J., and Zhang, Y. (2021). Higher urine exosomal miR-193a is associated with a higher probability of primary focal segmental glomerulosclerosis and an increased risk of poor prognosis among children with nephrotic syndrome. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.727370"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.ajkd.2014.07.013","article-title":"Plasma microRNA-186 and proteinuria in focal segmental glomerulosclerosis","volume":"65","author":"Zhang","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Esmaeilzadeh Aghjeh, M., Suer, I., Dirim, A.B., Kaya, M., and Ozturk, S. (2025). Advances in focal segmental glomerulosclerosis research: Genetic causes to non-coding RNAs. Mol. Biol. Rep., 52.","DOI":"10.1007\/s11033-025-10488-1"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000545240","article-title":"Recent advances in miRNA biomarkers for diagnosis and prognosis of focal segmental glomerulosclerosis","volume":"11","author":"Sun","year":"2025","journal-title":"Kidney Dis."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Doublier, S., Zennaro, C., Musante, L., Spatola, T., Candiano, G., Bruschi, M., Besso, L., Cedrino, M., Carraro, M., and Ghiggeri, G.M. (2017). Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0188045"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/jcb.25571","article-title":"CD154 induces matrix metalloproteinase-9 secretion in human podocytes","volume":"117","author":"Rigothier","year":"2016","journal-title":"J. Cell Biochem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cellimm.2006.08.001","article-title":"Differential regulation of soluble and membrane CD40L proteins in T cells","volume":"241","author":"Matthies","year":"2006","journal-title":"Cell Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/ndt\/gfw397","article-title":"IL-17 and CD40 ligand synergistically stimulate the chronicity of diabetic nephropathy","volume":"33","author":"Kuo","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1681\/ASN.V11122381","article-title":"Protein gene product 9.5 is selectively localized in parietal epithelial cells of bowman\u2019s capsule in the rat kidney","volume":"11","author":"Shirato","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1093\/ndt\/gfi124","article-title":"Protein gene product 9.5 and ubiquitin are expressed in metabolically active epithelial cells of normal and pathologic human kidney","volume":"20","author":"Lerut","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/path.2511","article-title":"UCH-L1 expression of podocytes in diseased glomeruli and in vitro","volume":"217","author":"Liu","year":"2009","journal-title":"J. Pathol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jaut.2017.12.014","article-title":"Autoantibodies against podocytic UCHL1 are associated with idiopathic nephrotic syndrome relapses and induce proteinuria in mice","volume":"89","author":"Jamin","year":"2018","journal-title":"J. Autoimmun."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Chebotareva, N., Cao, V., Vinogradov, A., Alentov, I., Sergeeva, N., Kononikhin, A., and Moiseev, S. (2023). Preliminary study of anti-CD40 and ubiquitin proteasome antibodies in primary podocytopaties. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1189017"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"108869","DOI":"10.1016\/j.clim.2021.108869","article-title":"Seven novel podocyte autoantibodies were identified to diagnosis a new disease subgroup-autoimmune podocytopathies","volume":"232","author":"Ye","year":"2021","journal-title":"Clin. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1681\/ASN.0000000525","article-title":"Autoantibodies targeting proteasome subunit alpha type 1 in autoimmune podocytopathies","volume":"36","author":"Liu","year":"2025","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.21037\/atm-21-3988","article-title":"The important roles and molecular mechanisms of annexin A(2) autoantibody in children with nephrotic syndrome","volume":"9","author":"Ye","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"256ra136","DOI":"10.1126\/scitranslmed.3008538","article-title":"A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation","volume":"6","author":"Delville","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1111\/ajt.17077","article-title":"Circulating nephrin autoantibodies and posttransplant recurrence of primary focal segmental glomerulosclerosis","volume":"22","author":"Hattori","year":"2022","journal-title":"Am. J. Transplant."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1681\/ASN.0000000642","article-title":"Anti-slit antibodies against podocin and Kirrel1 in pediatric and adult podocytopathies","volume":"36","author":"Raglianti","year":"2025","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1046\/j.1523-1755.2000.00434.x","article-title":"Effect of plasma fractions from patients with focal and segmental glomerulosclerosis on rat proteinuria","volume":"58","author":"Berre","year":"2000","journal-title":"Kidney Int."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.kint.2023.10.017","article-title":"Post-transplant recurrence of focal segmental glomerular sclerosis: Consensus statements","volume":"105","author":"Raina","year":"2024","journal-title":"Kidney Int."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1111\/j.1600-6143.2005.01112.x","article-title":"Preemptive plasmapheresis and recurrence of FSGS in High-Risk renal transplant recipients","volume":"5","author":"Gohh","year":"2005","journal-title":"Am. J. Transplant."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Shuster, S., Ankawi, G., Licht, C., Reiser, J., Wang, X., Wei, C., Chitayat, D., and Hladunewich, M. (2018). Fetal renal echogenicity associated with maternal focal segmental glomerulosclerosis: The effect of transplacental transmission of permeability factor suPAR. J. Clin. Med., 7.","DOI":"10.3390\/jcm7100324"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/00007890-199410000-00018","article-title":"Minimal-change glomerular nephritis: Normal kidneys in an abnormal environment?","volume":"58","author":"Ali","year":"1994","journal-title":"Transplantation"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/ndt\/16.2.416","article-title":"Successful transplant of a kidney with focal segmental glomerulosclerosis","volume":"16","author":"Rea","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1056\/NEJMc1202500","article-title":"Resolution of recurrent focal segmental glomerulosclerosis after retransplantation","volume":"366","author":"Gallon","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.ki.5001655","article-title":"Direct effects of dexamethasone on human podocytes","volume":"70","author":"Xing","year":"2006","journal-title":"Kidney Int."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nm.1857","article-title":"The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A","volume":"14","author":"Faul","year":"2008","journal-title":"Nat. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI82592","article-title":"A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis","volume":"126","author":"Yu","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2404211","article-title":"APOL1 bi- and monoallelic variants and chronic kidney disease in west africans","volume":"392","author":"Ifeoma","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa2202396","article-title":"Inaxaplin for proteinuric kidney disease in persons with two APOL1 variants","volume":"388","author":"Egbuna","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nm.4362","article-title":"A tripartite complex of suPAR, APOL1 risk variants and \u03b1(v)\u03b2(3) integrin on podocytes mediates chronic kidney disease","volume":"23","author":"Hayek","year":"2017","journal-title":"Nat. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1172\/JCI7728","article-title":"Nephritogenic mAb 5-1-6 is directed at the extracellular domain of rat nephrin","volume":"104","author":"Topham","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s00467-014-2781-z","article-title":"Congenital nephrotic syndrome and recurrence of proteinuria after renal transplantation","volume":"29","author":"Holmberg","year":"2014","journal-title":"Pediatr. Nephrol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00007890-200202150-00013","article-title":"Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the finnish type: Role of nephrin","volume":"73","author":"Patrakka","year":"2002","journal-title":"Transplantation"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2004030172","article-title":"Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, podocin, and CD2 associated protein in cultured human podocytes","volume":"16","author":"Coward","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0002-9440(10)64128-4","article-title":"Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome","volume":"158","author":"Doublier","year":"2001","journal-title":"Am. J. Pathol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ndt\/18.1.70","article-title":"Altered ultrastructural distribution of nephrin in minimal change nephrotic syndrome","volume":"18","author":"Wernerson","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e186769","DOI":"10.1172\/JCI186769","article-title":"Passive transfer of patient-derived anti-nephrin autoantibodies causes a podocytopathy with minimal change lesions","volume":"135","author":"Hengel","year":"2025","journal-title":"J. Clin. Investig."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Liu, P., Liu, S., Dalal, V., Lane, J., Cravedi, P., Campbell, K., Angeletti, A., Xie, X., Gessaroli, E., and Forte, E. (2024). Evaluation of methodologies in anti-nephrin autoantibody detection. bioRxiv.","DOI":"10.1101\/2024.07.25.605154"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"sfaf100","DOI":"10.1093\/ckj\/sfaf100","article-title":"Potential and pitfalls of measuring circulating anti-nephrin autoantibodies in glomerular diseases","volume":"18","author":"Hengel","year":"2025","journal-title":"Clin. Kidney J."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000545706","article-title":"Quo vadis standardization of anti-nephrin antibody detection?","volume":"5","author":"Mirioglu","year":"2025","journal-title":"Glomerular Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.kint.2018.10.030","article-title":"Development of a novel cell-based assay to diagnose recurrent focal segmental glomerulosclerosis patients","volume":"95","author":"Srivastava","year":"2019","journal-title":"Kidney Int."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/ndt\/gfaa211","article-title":"Novel in vitro assays to detect circulating permeability factor(s) in idiopathic focal segmental glomerulosclerosis","volume":"36","author":"Braanker","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.ekir.2022.09.014","article-title":"Circulating permeability factors in focal segmental glomerulosclerosis: In Vitro detection","volume":"7","author":"Veissi","year":"2022","journal-title":"Kidney Int. Rep."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.kint.2025.01.018","article-title":"A kidney organoid-based readout to assess disease activity in primary and recurrent focal segmental glomerulosclerosis","volume":"107","author":"Gupta","year":"2025","journal-title":"Kidney Int."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1681\/ASN.2021111472","article-title":"Long-term efficacy and safety of repeated rituximab to maintain remission in idiopathic childhood nephrotic syndrome: An international study","volume":"33","author":"Chan","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"114795","DOI":"10.1016\/j.intimp.2025.114795","article-title":"The efficacy and safety of rituximab in adult patients with steroid-dependent or frequent relapsing nephrotic syndrome: A retrospective study","volume":"158","author":"Huang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000535010","article-title":"Efficacy of rituximab for minimal change disease and focal segmental glomerulosclerosis with frequently relapsing or steroid-dependent nephrotic syndrome in adults: A chinese multicenter retrospective study","volume":"55","author":"Lan","year":"2024","journal-title":"Am. J. Nephrol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1681\/ASN.0000000520","article-title":"Long-term outcomes of rituximab-treated adult patients with podocytopathies","volume":"36","author":"Gauckler","year":"2025","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1111\/ajt.16504","article-title":"Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: Results of a nationwide study","volume":"21","author":"Lanaret","year":"2021","journal-title":"Am. J. Transplant."}],"container-title":["Antibodies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4468\/14\/4\/82\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:55:14Z","timestamp":1759229714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4468\/14\/4\/82"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,28]]},"references-count":125,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["antib14040082"],"URL":"https:\/\/doi.org\/10.3390\/antib14040082","relation":{},"ISSN":["2073-4468"],"issn-type":[{"value":"2073-4468","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,28]]}}}